Mildred Ezekiel

Antihypertensive Effects of the Endothelin Receptor Antagonist BQ-123 in Conscious Spontaneously Hypertensive Rats

Eliot H. Ohlstein, Stephen A. Douglas, Mildred Ezekiel et al. · Journal of Cardiovascular Pharmacology · 1993 · 47 citations

Hypertension, Cardiovascular Disease, Atherosclerosis +12

BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension

Stephen A. Douglas, Miklos Gellai, Mildred Ezekiel et al. · Journal of Hypertension · 1994 · 47 citations

Substituted 1-benzylimidazole-2-thiols as potent and orally active inhibitors of dopamine .beta.-hydroxylase

Lawrence I. Kruse, Carl Kaiser, Walter E. DeWolf et al. · Journal of Medicinal Chemistry · 1986 · 40 citations · Full text

Drug Target, Altmetric Attention Score, Pharmacotherapy +18

Antihypertensive Actions of the Novel Nonpeptide Endothelin Receptor Antagonist SB 209670

Stephen A. Douglas, Miklos Gellai, Mildred Ezekiel et al. · Hypertension · 1995 · 38 citations

Molecular Pharmacology, Hypertension, Indirect Evidence +14

.beta.-Substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine .beta.-hydroxylase

Lawrence I. Kruse, Carl Kaiser, Walter E. DeWolf et al. · Journal of Medicinal Chemistry · 1988 · 34 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Donut Icon +14